BioCentury
ARTICLE | Clinical News

Centocor regulatory update

January 16, 1995 8:00 AM UTC

The Malvern, Penn., company received FDA approval for two diagnostics, for syphilis and ovarian cancer. CAPTIA Syphilis-G, an infectious disease serology test, received 510 (k) approval for use as a p...